Study of 9cUAB30 in Healthy Participants
Completed · Phase 1
Conditions studied: No Evidence of Disease
In brief
This research study is looking at 9cUAB30 in healthy participants. Studying samples of blood and urine from healthy participants may help doctors learn more about how 9cUAB30 is used by the body.
Key facts
- Study ID
- NCT00896974
- Run by
- National Cancer Institute (NCI)
- People needed
- 15
- Starts
- 2008-08-01
- Expected to finish
- 2010-03-01
- Last updated by the study team
- 2015-06-18
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy volunteer
- Karnofsky performance status (PS) 70-100% (ECOG PS 0-1)
- WBC ≥ 3,000/mm³
- Platelet count ≥ 100,000mm³
- Hemoglobin > 10 g/dL
- Bilirubin ≤ 1.4 mg/dL
- AST ≤ 1.5 times normal
- Creatinine normal
- Sodium 135-144 mmol/L
- Potassium 3.2-4.8 mmol/L
- Chloride 85-114 mmol/L
- Bicarbonate > 11 mEQ/dL
- Fasting triglycerides ≤ 1.5 times upper limit of normal (ULN)
- Fasting cholesterol ≤ 1.5 times ULN
- Not pregnant or nursing
- No nursing during and for 30 days after completion of study treatment
- Negative pregnancy test
- Fertile participants must use effective contraception prior to, during, and for 1 month after completion of study treatment
- No low-dose progesterone only birth control pills
- No concurrent uncontrolled illness including, but not limited to, any of the following:
- Ongoing or active infection
- Symptomatic congestive heart failure
- Unstable angina pectoris
- Cardiac arrhythmia
- Psychiatricillness or social situation that would limit compliance with study requirements
Where it is running
- University of Wisconsin Hospital and Clinics — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.